Omnicell Inc
NASDAQ:OMCL
Omnicell Inc
Revenue
Omnicell Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Omnicell Inc
NASDAQ:OMCL
|
Revenue
$1.1B
|
CAGR 3-Years
9%
|
CAGR 5-Years
8%
|
CAGR 10-Years
12%
|
|
Veeva Systems Inc
NYSE:VEEV
|
Revenue
$2.4B
|
CAGR 3-Years
17%
|
CAGR 5-Years
22%
|
CAGR 10-Years
27%
|
|
Inspire Medical Systems Inc
NYSE:INSP
|
Revenue
$624.8m
|
CAGR 3-Years
76%
|
CAGR 5-Years
65%
|
CAGR 10-Years
N/A
|
|
Evolent Health Inc
NYSE:EVH
|
Revenue
$2B
|
CAGR 3-Years
29%
|
CAGR 5-Years
26%
|
CAGR 10-Years
N/A
|
|
Doximity Inc
NYSE:DOCS
|
Revenue
$419.1m
|
CAGR 3-Years
53%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Goodrx Holdings Inc
NASDAQ:GDRX
|
Revenue
$750.3m
|
CAGR 3-Years
11%
|
CAGR 5-Years
25%
|
CAGR 10-Years
N/A
|
Omnicell Inc
Revenue Breakdown
Breakdown by Geography
Omnicell Inc
Total Revenue:
1.1B
USD
|
United States:
1B
USD
|
Rest Of World:
135.7m
USD
|
Breakdown by Segments
Omnicell Inc
Total Revenue:
1.1B
USD
|
Product Revenues:
708.6m
USD
|
Connected Devices, Software Licenses, And Other:
623.6m
USD
|
Services And Other Revenues:
438.6m
USD
|
Technical Services:
225.8m
USD
|
Advanced Services:
212.7m
USD
|
Consumables:
85m
USD
|
See Also
What is Omnicell Inc's Revenue?
Revenue
1.1B
USD
Based on the financial report for Dec 31, 2023, Omnicell Inc's Revenue amounts to 1.1B USD.
What is Omnicell Inc's Revenue growth rate?
Revenue CAGR 10Y
12%
Over the last year, the Revenue growth was -11%. The average annual Revenue growth rates for Omnicell Inc have been 9% over the past three years , 8% over the past five years , and 12% over the past ten years .